Getinge’s innovative solutions for life support and therapies
In Korea last year, the demand for advanced medical technology was underscored by close to 90,000 cardiovascular procedures, over 15,000 open-heart surgeries, and 3,000 Extracorporeal Membrane Oxygenation (ECMO) procedures performed*. Medtech supplier Getinge, with a strong presence in the region, is renowned for its world-class ECMO solutions and a comprehensive portfolio designed for acute health conditions.
“Our acute care solutions are instrumental in saving 10 million lives globally each year,” states Philippe Rocher, President South Asia Pacific at Getinge. “We are committed to innovation, with significant investments in R&D to advance the efficiency and effectiveness of acute care, for example with our state-of-the-art ventilators and ECMO solutions.”
Cardiogenic shock, acute respiratory distress syndrome, septic shock or pulmonary embolisms are conditions that can become life-threatening. Patients with severe cardiac and/or pulmonary failure require immediate support to maintain gas exchange and end-organ perfusion. Extracorporeal Membrane Oxygenation (ECMO) provides clinicians with a powerful option to help stabilize blood circulation and/or respiratory functions of affected patients. 
Dr. Jae-Seung Jung, Chief of Department of Thoracic & Cardiovascular Surgery at Korea University Anam Hospital, attests to the transformative impact of Getinge’s ECMO solutions in patient care.
“ECMO has advanced with incomparable outcomes over the decades, particularly demonstrating its essential role during the pandemic in treating severe heart and lung conditions. Getinge's ECMO solutions have played a pivotal role in saving lives by delivering advanced technology, unwavering reliability, and crucial support to our patients.”
APELSO 2023, scheduled for November 2-4 in Seoul, presents an exclusive opportunity for attendees to explore Getinge’s acute care therapies portfolio, highlighting innovations for ECMO and cardiovascular procedures.
‘Through efforts in supporting educational events such as APELSO, we improve clinicians’ ability to save more lives and reduce long-term complications. This brings us closer to our purpose of making life-saving technology accessible for more people’ adds Philippe Rocher.
Getinge’s commitment to efficiency and innovation underscores its role as a leader in the medtech space, offering solutions that seamlessly blend life-saving capabilities with operational efficiency, a critical combination in today’s fast-paced healthcare environment.
*Data from HIRA (https://opendata.hira.or.kr/op/opc/olapDiagBhvInfoTab1.do)